Level 2

Company Announcements

Expiry of Unlisted Options

Related Companies

By LSE RNS

RNS Number : 2247N
Oilex Ltd
07 August 2017
 

 

ASX Announcement

 

07 August 2017

 

ASX: OEX

AIM: OEX

 

 

 

Expiry of Unlisted Options

 

Oilex Ltd wishes to advise that 275,000 employee options with an exercise price of $0.25 and an expiry date of 5 August 2017 have expired unexercised.

 

Attached is an Appendix 3B.

 

 

For and on behalf of Oilex Ltd

 

 

 

 

Mark Bolton

Chief Financial Officer & Company Secretary

 

 

 

 

 

 

 

 

 

 

For further information, please contact:

 

Investor Enquiries

Oilex Ltd

Joe Salomon

Managing Director

Email: oilex@oilex.com.au

Tel: +61 8 9485 3200

Australia

AIM Broker

Cornhill Capital Limited

Daniel Gee

Email: danielg@cornhillcapital.com

Tel: +44 20 3700 2500

UK

AIM Nominated Adviser

Strand Hanson Limited

Nominated Adviser

Rory Murphy/Ritchie Balmer   

Email: oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

Media Enquires (UK)

Vigo Communications

Public Relations

Patrick d'Ancona/Chris McMahon

Email: patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel:   +44 20 7830 9700

Media Enquiries (Aus)

Citadel-MAGNUS

Michael Weir

Email:

Tel: +618 6160 4900

Australia

 

 

 


 

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

New issue announcement,

application for quotation of additional securities

and agreement

 

Information or documents not available now must be given to ASX as soon as available.  Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96  Origin: Appendix 5  Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

 

 

Name of entity

 

OILEX LTD

 

ABN

 

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1

+Class of +securities issued or to be issued

 

Not applicable


 

 

2

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

 

Not applicable


 

 

3

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

Not applicable

 

 

 

 

                             

             


4

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·  the date from which they do

·  the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·  the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

Not applicable

 

 




5

Issue price or consideration

 

Not applicable

 






 

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

Not applicable






 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

Yes






 

6b

The date the security holder resolution under rule 7.1A was passed

 

23 November 2016






 

6c

Number of +securities issued without security holder approval under rule 7.1

 

Not applicable






 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

Not applicable






 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

Not applicable



 

6f

 

Number of +securities issued under an exception in rule 7.2

 

 Not applicable



 

6g

If +securities issued under rule 7.1A was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values.  Include the source of the VWAP calculation.

 

Not applicable



 

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

Not applicable


6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

Listing Rule 7.1:      215,638,022

Listing Rule 7.1A:      35,509,166



 

7

+Issue dates

Notes:  The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12).  For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in appendix 7A.

 

Cross reference: item 33 of Appendix 3B.

 

Not applicable

 


 

 

8

Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable)

Number

+Class

 

1,684,302,899

 

 

 

Fully Paid Ordinary Shares

 



 

9

Number and +class of all +securities not quoted on ASX (including the securities in section 2 if applicable)

 

 

 

 

 

 

Number

+Class

 

2,000,000

5,000,000

275,000

 

190,535,385

 

88,888,888

 

 

 

$0.25 Options due 11/11/2017

$0.10 Options due 22/12/2017

$0.35 Options due 05/08/2018

 

£0.0035 Options due

                             22/11/2017

£0.00225 Options due

                             22/05/2020



 

10

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

Not applicable

 



 

 

Part 2 ‑ Pro rata issue

 

11

Is security holder approval required?

 

Not applicable



 

12

Is the issue renounceable or non-renounceable?

 



 

13

Ratio in which the +securities will be offered

 



 

14

+Class of +securities to which the offer relates

 



 

15

+Record date to determine entitlements

 

 



 

16

Will holdings on different registers (or subregisters) be aggregated for calculating entitlements?

 



 

17

Policy for deciding entitlements in relation to fractions

 

 



 

18

Names of countries in which the entity has security holders who will not be sent new issue documents

Note: Security holders must be told how their entitlements are to be dealt with.

Cross reference: rule 7.7.

 



 

19

Closing date for receipt of acceptances or renunciations

 

 

 

 

 



20

Names of any underwriters

 

 

 



 

21

Amount of any underwriting fee or commission

 



 

22

Names of any brokers to the issue

 

 

 



 

23

Fee or commission payable to the broker to the issue

 

 

 



 

 



 



 

24

Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders

 



 

25

If the issue is contingent on security holders' approval, the date of the meeting

 



 

26

Date entitlement and acceptance form and offer documents will be sent to persons entitled

 



 

27

If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

 



 

28

Date rights trading will begin (if applicable)

 



 

29

Date rights trading will end (if applicable)

 

 

 



 

30

How do security holders sell their entitlements in full through a broker?

 



 

31

How do security holders sell part of their entitlements through a broker and accept for the balance?

 



 

32

How do security holders dispose of their entitlements (except by sale through a broker)?

 



 

33

+Issue date

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

o

+Securities described in Part 1




(b)

o

All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 


Entities that have ticked box 34(a)

 

 

Additional securities forming a new class of securities

 

 

Tick to indicate you are providing the information or documents

 




35


If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders




36


If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories

1 - 1,000

1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over




37


A copy of any trust deed for the additional +securities




Entities that have ticked box 34(b)

 

 

38

Number of securities for which +quotation is sought

 

 

Not applicable




39

+Class of +securities for which quotation is sought

 





40

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

 

If the additional +securities do not rank equally, please state:

·    the date from which they do

·    the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·    the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment





41

Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

 

(if issued upon conversion of another +security, clearly identify that other +security)

 




 




42

Number and +class of all +securities quoted on ASX (including the securities in clause 38)

 

 

Number

+Class



 

 

 

Quotation agreement

 

1          +Quotation of our additional +securities is in ASX's absolute discretion.  ASX may quote the +securities on any conditions it decides. 

 

2          We warrant the following to ASX.

 

·           The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

 

·           There is no reason why those +securities should not be granted +quotation.

 

·           An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·           Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

 

·           If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3          We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4          We give ASX the information and documents required by this form.  If any information or document not available now, will give it to ASX before +quotation of the +securities begins.  We acknowledge that ASX is relying on the information and documents.  We warrant that they are (will be) true and complete.

             

 

Mark Bolton

Company Secretary

 



 

Appendix 3B - Annexure 1

 

Calculation of placement capacity under rule 7.1 and rule 7.1A for +eligible entities

Introduced 01/08/12, Amended 04/03/13

 

Part 1

 

Rule 7.1 - Issues exceeding 15% of capital

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

Insert number of fully paid +ordinary securities on issue 12 months before the +issue date or date of agreement to issue

1,180,426,999

Add the following:

•    Number of fully paid +ordinary securities issued in that 12 month period under an exception in rule 7.2

 

 

 

12,987,013 (issued 23/11/2016)

 2,000,000 (issued 17/3/2017)

 

·      Number of fully paid +ordinary securities issued in that 12 month period with shareholder approval

Approval as at 3 May 2017 General Meeting

162,738,273 (issued 24/03/2017)

190,353,385 (issued 10/05/2017)

•    Number of partly paid +ordinary securities that became fully paid in that 12 month period

 

Note:

•     Include only ordinary securities here - other classes of equity securities cannot be added

•     Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

•      It may be useful to set out issues of securities on different dates as separate line items

 

Subtract the number of fully paid +ordinary securities cancelled during that 12 month period

Nil

"A"

1,548,505,670

 

Step 2: Calculate 15% of "A"

"B"

0.15

[Note: this value cannot be changed]

Multiply "A" by 0.15

232,275,850

Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used

Insert number of +equity securities issued or agreed to be issued in that 12 month period not counting those issued:

•    Under an exception in rule 7.2

•    Under rule 7.1A

•    With security holder approval under rule 7.1 or rule 7.4

Note:

•    This applies to equity securities, unless specifically excluded - not just ordinary securities

•    Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

•    It may be useful to set out issues of securities on different dates as separate line items

16,273,828 shares (issued 31/3/2017)

     182,000 shares (issued 10/05/2017)

     182,000 options (issued 22/05/2017)

 

 

"C"

16,637,828

Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1

"A" x 0.15

Note: number must be same as shown in Step 2

232,275,850

Subtract "C"

Note: number must be same as shown in Step 3

16,637,828

Total ["A" x 0.15] - "C"

215,638,022

 

[Note: this is the remaining placement capacity under rule 7.1]

 



 

Part 2

 

Rule 7.1A - Additional placement capacity for eligible entities

Step 1: Calculate "A", the base figure from which the placement capacity is calculated

"A"

Note: number must be same as shown in Step 1 of Part 1

1,548,505,670

Step 2: Calculate 10% of "A"

"D"

0.10

Note: this value cannot be changed

Multiply "A" by 0.10

154,850,567

Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

•     This applies to equity securities - not just ordinary securities

•     Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed

•     Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

•     It may be useful to set out issues of securities on different dates as separate line items

 

108,492,182 (issued 24/03/2017)

  10,849,218 (issued 31/03/2017)

"E"

119,341,401

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A

"A" x 0.10

Note: number must be same as shown in Step 2

154,850,567

 

Subtract "E"

Note: number must be same as shown in Step 3

119,341,401

Total ["A" x 0.10] - "E"

35,509,166

Note: this is the remaining placement capacity under rule 7.1A

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFDLBBDVFFBBD

Top of Page